Cargando…
Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy
The link between signaling pathways and diseases suggests the importance of pathway analysis for drug discovery. This includes target identification and validation, compound mode of action and drug candidate optimization. Here, we propose to apply cell signaling pathway panel approaches for oncology...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941151/ https://www.ncbi.nlm.nih.gov/pubmed/24665207 http://dx.doi.org/10.4137/CGM.S11134 |
_version_ | 1782305876324909056 |
---|---|
author | Schweizer, Liang Zhang, Litao |
author_facet | Schweizer, Liang Zhang, Litao |
author_sort | Schweizer, Liang |
collection | PubMed |
description | The link between signaling pathways and diseases suggests the importance of pathway analysis for drug discovery. This includes target identification and validation, compound mode of action and drug candidate optimization. Here, we propose to apply cell signaling pathway panel approaches for oncology drug discovery. The strategies and guiding principles of the pathway panel approach are discussed. 2 pathway analysis examples with related processes and technology platforms are illustrated to identify cancer drugs that target cancer growth and metastasis. Finally, we highlight potential challenges and opportunities presented by the pathway panel approach. |
format | Online Article Text |
id | pubmed-3941151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-39411512014-03-24 Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy Schweizer, Liang Zhang, Litao Cancer Growth Metastasis The link between signaling pathways and diseases suggests the importance of pathway analysis for drug discovery. This includes target identification and validation, compound mode of action and drug candidate optimization. Here, we propose to apply cell signaling pathway panel approaches for oncology drug discovery. The strategies and guiding principles of the pathway panel approach are discussed. 2 pathway analysis examples with related processes and technology platforms are illustrated to identify cancer drugs that target cancer growth and metastasis. Finally, we highlight potential challenges and opportunities presented by the pathway panel approach. Libertas Academica 2013-08-20 /pmc/articles/PMC3941151/ /pubmed/24665207 http://dx.doi.org/10.4137/CGM.S11134 Text en © 2013 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. |
spellingShingle | Schweizer, Liang Zhang, Litao Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy |
title | Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy |
title_full | Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy |
title_fullStr | Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy |
title_full_unstemmed | Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy |
title_short | Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy |
title_sort | enhancing cancer drug discovery through novel cell signaling pathway panel strategy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941151/ https://www.ncbi.nlm.nih.gov/pubmed/24665207 http://dx.doi.org/10.4137/CGM.S11134 |
work_keys_str_mv | AT schweizerliang enhancingcancerdrugdiscoverythroughnovelcellsignalingpathwaypanelstrategy AT zhanglitao enhancingcancerdrugdiscoverythroughnovelcellsignalingpathwaypanelstrategy |